Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes. Biomol Biomed [Internet]. 2023 Mar. 16 [cited 2025 Apr. 17];23(2):189–190. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/8874